James Sorrentino, Salvador Martínez-Bartolomé, Mahan Abbasian, Antonius Koller, Denice Hickman, Alexis Khalil, Nikhil Pandit, Kim Horrigan, Mary-Elizabeth Percival, Derek Stirewalt, Alfonso Quintas-Cardama, Pilgrim Jackson. "Machine learning-powered integration of global proteomics and ex vivo sensitivity unveils a protein signature predictive of treatment success to AML therapy: Validation in patients treated with FHD-286, a SMARCA2/4 dual inhibitor." Blood, 2025. doi:10.1182/blood-2025-3498